Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „CTCAE“
Suchtreffer
Begriffe & Kennungen
Abiraterone Mylan · 4.8 · The following CTCAE (version 4.0) Grade 3 adverse reactions occurred in patients treated with abiraterone acet
Eintrag öffnenAvastin · 4.8 · Across clinical trials, the following Grade 3 and 4 (NCI-CTCAE v.3) laboratory abnormalities occurred in patie
Eintrag öffnenAvastin · 4.8 · Grade 3-5 (NCI-CTCAE v.3) venous thromboembolic reactions have been reported in up to 7.8% of patients treated
Eintrag öffnenAvastin · 4.8 · Haemorrhage (see section 4.4) In clinical trials across all indications the overall incidence of NCI-CTCAE v.3
Eintrag öffnenBesremi · 4.8 · Table 1. Most common adverse reactions during ropeginterferon alfa-2b treatment. CTCAE Medicinal Medicinal Dos
Eintrag öffnenBrukinsa · 4.8 · CTCAE) version 4.03. † Based on laboratory measurements. ± Percentages are based on number of patients with bo
Eintrag öffnenBrukinsa · 4.8 · CTCAE) version 4.03. † Based on laboratory measurements. ± Percentages are based on number of patients with bo
Eintrag öffnenCalquence · 4.8 · * Per National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) version 4.03. † Inc
Eintrag öffnenEnhertu · 4.8 · The most common National Cancer Institute – Common Terminology Criteria for Adverse Events (NCI-CTCAE v.5.0) G
Eintrag öffnenEnhertu · 4.8 · The most common National Cancer Institute – Common Terminology Criteria for Adverse Events (NCI-CTCAE v.5.0) G
Eintrag öffnenEtcamah · 4.8 · Visual effects Of the 40.7% patients who reported visual effects, the majority (92.5%) experienced CTCAE Grade
Eintrag öffnenGazyvaro · 4.8 · C=cycle; CTCAE = Common Terminology Criteria for Adverse Events; IRR=infusion related reaction a Infusion rela
Eintrag öffnenGazyvaro · 4.8 · CTCAE C1 C1b by day C2C C3 C4 C5 C6 C7 Over all Grade Overall induction (standard cycles infusion) Day 1 Day 2
Eintrag öffnenHemgenix · 4.8 · 12 c CTCAE Grade 1 d CTCAE Grade 2 e CTCAE Grade 3 f Adverse event data are derived from patients followed for
Eintrag öffnenHerceptin · 4.8 · The rate of severe infections (NCI CTCAE grade ≥3) was 5.0 % versus 7.1 %, in the Herceptin intravenous formul
Eintrag öffnenImfinzi · 4.8 · The most common (> 2%) NCI CTCAE Grade ≥ 3 adverse reactions were neutropenia (25.2%), anaemia (23.5%), leukop
Eintrag öffnenImfinzi · 4.8 · The severity of adverse drug reactions was assessed based on the CTCAE, defining grade 1=mild, grade 2=moderat
Eintrag öffnenInaqovi · 4.8 · 10 AML monotherapy (N=80), AML combination therapy (N=189) or IV decitabine MedDRA SOC MedDRA Term a All CTCAE
Eintrag öffnenInaqovi · 4.8 · 9 AML monotherapy (N=80), AML combination therapy (N=189) or IV decitabine MedDRA SOC MedDRA Term a All CTCAE
Eintrag öffnenInaqovi · 4.8 · CTCAE= Common Terminology Criteria for Adverse Events
Eintrag öffnen